Winton Capital »

Rigel Pharmaceuticals shares owned by Winton Capital

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Winton Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $314k 11k 28.33

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Ge Vernova (GEV)
Select Sector Spdr Tr Sbi Materials (XLB)
Devon Energy Corporation (DVN)
Interactive Brokers Group In Com Cl A (IBKR)
Meta Platforms Cl A (META)
Uber Technologies (UBER)
Fastenal Company (FAST)
Incyte Corporation (INCY)
Masco Corporation (MAS)
Five Below (FIVE)
Johnson Ctls Intl SHS (JCI)

View all positions for Winton Capital

Top funds holding Rigel Pharmaceuticals

BlackRock
Morgan Stanley
Vanguard Group
Goldman Sachs Group
Armistice Capital
Acadian Asset Management
Marshall Wace
Capitolis Liquid Global Markets
State Street Corporation
Renaissance Technologies
Geode Capital Management
Qube Research & Technologies
Jane Street
Soleus Capital Management
D. E. Shaw & Co

View all funds holding Rigel Pharmaceuticals